The Prediction Model of Avastin Plus Chemotherapy in Unresectable Ras Mutant CRLM Patients

Effect of Target Therapy on Patients Undergoing Synchronic Hepatectomy for Colorectal Liver Metastases

NCT01677728 ·Status: UNKNOWN

Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer

NCT01781403 ·Status: COMPLETED ·Phase: PHASE1

The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer

NCT02523495 ·Status: UNKNOWN

New Genes in the Carcinogenesis of Colorectal Cancer

NCT03261752 ·Status: UNKNOWN

Multimodal Model for Efficacy Prediction Cetuximab in Colorectal Cancer Liver Metastasis Patient

NCT05873972 ·Status: UNKNOWN ·Phase: NA

Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer

NCT02688023 ·Status: UNKNOWN ·Phase: PHASE2

Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer

NCT06231017 ·Status: RECRUITING ·Phase: PHASE2

Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases

NCT04687631 ·Status: RECRUITING ·Phase: PHASE3

Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM

NCT03127072 ·Status: UNKNOWN ·Phase: PHASE4

Oligometastases of the LIVer Treated With Chemotherapy With ou Without Extracranial Stereotactic Body Radiation Therapy in Patients With Colorectal Cancer

NCT03532204 ·Status: WITHDRAWN ·Phase: NA

Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients

NCT01523431 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study Comparing HAI Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM

NCT03125161 ·Status: UNKNOWN ·Phase: PHASE3

Translational Research in Identifying Molecular Mechanisms for Rectal Cancer Metastasis

NCT02979795 ·Status: UNKNOWN

Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy

NCT00414232 ·Status: COMPLETED

Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases

NCT04525326 ·Status: UNKNOWN ·Phase: PHASE3

Safety of Cetuximab and Trifluridin Tipiracil as the Third-line Therapy in the RASwt mCRC

NCT05155124 ·Status: UNKNOWN ·Phase: PHASE1

Study of Intramural Spread Pattern in Low Rectal Cancer.

NCT07202169 ·Status: COMPLETED

Tumor Response Prediction in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer Using Metabonomics Analysis

NCT03149978 ·Status: UNKNOWN

The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy

NCT05640726 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety

NCT01465451 ·Status: UNKNOWN ·Phase: PHASE3

The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey

NCT01549067 ·Status: UNKNOWN

Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer

NCT03532711 ·Status: COMPLETED

Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis

NCT02453490 ·Status: TERMINATED ·Phase: PHASE3

Genomic Signatures for Patients With Initially Unresectable Colorectal Liver Metastases

NCT06477718 ·Status: COMPLETED

The Gene Profiles of Primary and Heterogeneous Metastases of Colorectal Cancer

NCT04230018 ·Status: UNKNOWN